DYNOCARDIA, INC.
NEWTON CENTER, MA · Founded 2018 · CIK 0001776173 · Medtech · Private
ViTrack, a cuffless wrist-wearable device that measures blood pressure continuously and non-invasively using pressure-dependent skin displacement
dynocardia.care →- Grants
- $5.8M
- 8 awards
- Sector median: 1
- Raised
- $2.9M
- 4 Form D · Mar 2025
- 19 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 7
- 1 granted · 6 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20182019202020212022202320242025
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $340,000 | |
| Private capital raised | Form D · SEC | $350,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of a novel cuff-less wrist wearable continuous blood pressure monitor | $973,855 | |
| Federal grant | National Science Foundation · Phase I · SBIR Phase I: Motion artifact management for accurate and continuous non-invasive blood pressure monitoring | $256,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of a novel cuff-less wrist wearable continuous blood pressure monitor | $1,016,328 | |
| Federal grant | Department of Health and Human Services · Phase II · Continuous non-invasive assessment of blood pressure profile in persons with Alzheimer's and its related dementias | $153,969 | |
| Federal grant | Department of Health and Human Services · Phase II · ViTrack: Wearable, accurate, continuous blood pressure monitor to improve outcomes in hypertensive diseases of pregnancy | $1,168,681 | |
| Private capital raised | Form D · SEC | $1,500,000 | |
| Federal grant | Department of Health and Human Services · Phase II · ViTrack: Wearable, accurate, continuous blood pressure monitor to improve outcomes in hypertensive diseases of pregnancy | $99,682 | |
| Federal grant | National Science Foundation · Phase II · SBIR Phase II: Development of motion artifact correction systems for ViTrack: an accurate, continuous, and non-invasive blood pressure monitor | $999,553 | |
| Federal grant | Department of Health and Human Services · Phase II · ViTrack: Wearable, accurate, continuous blood pressure monitor to improve outcomes in hypertensive diseases of pregnancy | $1,157,562 | |
| Private capital raised | Form D · SEC | $675,324 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1236 | Scanadu Inc | — | $45M |
| 1237 | Liquid Lung DX, Inc. | — | $70K |
| 1238 | ADVANCED MEDICAL DEVICE TECHNOLOGIES, INC. | — | — |
| 1239 | DYNOCARDIA, INC. | — | $2.9M |
| 1240 | ACTUS INTERACTIVE SOFTWARE LLC | — | $243K |
| 1241 | BIOCIRCUIT TECHNOLOGIES, INC. | — | $14M |
| 1242 | APC AVE 20, LLC | — | $1.7M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Mohan ThanikachalamDirector · Executive Officer
Patents
- Spatiotemporal-based Detection And Correction Of Motion Artifact For Measurement Of Arterial Pressure Waveformapplication
- Spatiotemporal-based Detection And Correction Of Motion Artifact For Measurement Of Arterial Pressure Waveformgranted
- Optomechanical Method to Measure Arterial Pulse and Assess Cardiopulmonary Hemodynamicsapplication
- Optical Method For Measuring Arterial Pulsationapplication
- Spatiotemporal-based Detection And Correction Of Motion Artifact For Measurement Of Arterial Pressure Waveformapplication
- Spatiotemporal-based Detection And Correction Of Motion Artifact For Measurement Of Arterial Pressure Waveformapplication
- Optomechanical Method To Measure Arterial Pulse And Assess Cardiopulmonary Hemodynamicsapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.